Authors: Lesaffre, E Bluhmki, E Wang-Clow, F Berioli, S Danays, T Fox, NL Van de Werf, F

Citation: E. Lesaffre et al., The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction, EUR HEART J, 22(11), 2001, pp. 898-902

Authors: Wang-Clow, F Lynn, N Cannon, CP Gibson, M Berioli, S Bluhmki, E Danays, T Braunwald, E Van De Werf, F Stump, DC

Citation: F. Wang-clow et al., Determination of a weight-adjusted dose of TNK-tissue plasminogen activator, AM HEART J, 141(1), 2001, pp. 33-40

Authors: Van de Werf, F Cannon, CP Luyten, A Houbracken, K McCabe, CH Berioli, S Bluhmki, E Sarelin, H Wang-Clow, F Fox, NL Braunwald, E

Citation: F. Van De Werf et al., Safety assessment of single-bolus administration of TNK tissue-plasminogenactivator in acute myocardial infarction: The ASSENT-1 trial, AM HEART J, 137(5), 1999, pp. 786-791